US Stock MarketDetailed Quotes

CPRX Catalyst Pharmaceuticals

Watchlist
  • 23.270
  • +0.010+0.04%
Close Feb 14 16:00 ET
  • 23.070
  • -0.200-0.86%
Post 20:01 ET
2.78BMarket Cap19.72P/E (TTM)

Catalyst Pharmaceuticals Key Stats

Catalyst Pharmaceuticals Q4 2024 Estimates Date

Currency:USDFeb 26, 2025

Estimate YoY
Revenue
134.20M
+21.37%
EPS
0.34
+17.72%
Strong Buy

Feb 11, 2025

Catalyst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 127.926M--
Feb 26, 20252024/Q4-- / 134.197M--
Nov 6, 20242024/Q3128.695M / 123.421M--
Aug 7, 20242024/Q2122.710M / 111.867M--
May 8, 20242024/Q198.509M / 98.775M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 127.926M--
Feb 26, 20252024/Q4-- / 134.197M--
Nov 6, 20242024/Q3128.695M / 123.421M--
Aug 7, 20242024/Q2122.710M / 111.867M--
May 8, 20242024/Q198.509M / 98.775M--

Unlock Free Earnings Estimates

Catalyst Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now